Cargando…

Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states

Clear cell renal cell carcinoma (ccRCC) is molecularly heterogeneous, immune infiltrated, and selectively sensitive to immune checkpoint inhibition (ICI). However, the joint tumor-immune states that mediate ICI response remain elusive. We develop spatially aware deep-learning models of tumor and imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyman, Jackson, Denize, Thomas, Bakouny, Ziad, Labaki, Chris, Titchen, Breanna M., Bi, Kevin, Hari, Surya Narayanan, Rosenthal, Jacob, Mehta, Nicita, Jiang, Bowen, Sharma, Bijaya, Felt, Kristen, Umeton, Renato, Braun, David A., Rodig, Scott, Choueiri, Toni K., Signoretti, Sabina, Van Allen, Eliezer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518628/
https://www.ncbi.nlm.nih.gov/pubmed/37729872
http://dx.doi.org/10.1016/j.xcrm.2023.101189
Descripción
Sumario:Clear cell renal cell carcinoma (ccRCC) is molecularly heterogeneous, immune infiltrated, and selectively sensitive to immune checkpoint inhibition (ICI). However, the joint tumor-immune states that mediate ICI response remain elusive. We develop spatially aware deep-learning models of tumor and immune features to learn representations of ccRCC tumors using diagnostic whole-slide images (WSIs) in untreated and treated contexts (n = 1,102 patients). We identify patterns of grade heterogeneity in WSIs not achievable through human pathologist analysis, and these graph-based “microheterogeneity” structures associate with PBRM1 loss of function and with patient outcomes. Joint analysis of tumor phenotypes and immune infiltration identifies a subpopulation of highly infiltrated, microheterogeneous tumors responsive to ICI. In paired multiplex immunofluorescence images of ccRCC, microheterogeneity associates with greater PD1 activation in CD8(+) lymphocytes and increased tumor-immune interactions. Our work reveals spatially interacting tumor-immune structures underlying ccRCC biology that may also inform selective response to ICI.